Results 231 to 240 of about 6,967 (325)

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose

open access: yesPediatric Blood &Cancer, Volume 73, Issue 6, June 2026.
ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender   +17 more
wiley   +1 more source

Tracheal Extramedullary Plasmacytoma Causing Near‐Complete Airway Obstruction in an HIV‐Positive Man: A Case Report and Brief Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT A 53‐year‐old HIV‐positive man presented with progressive dyspnea, hoarseness, and near‐complete tracheal obstruction. Computed tomography and rigid bronchoscopy identified a > 90% obstructing tracheal mass. Histopathology with immunohistochemistry confirmed extramedullary plasmacytoma.
Filmon Tsegay   +10 more
wiley   +1 more source

Precision Medicine in a Patient With Multiple Myeloma Presenting With t(2;11) and CCND1 Overexpression

open access: yeseJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Translocations involving CCND1 are well described in multiple myeloma (MM), most frequently t(11;14), but rearrangements involving the immunoglobulin kappa (IGK) locus are rare. We present a case of a 71‐year‐old female with MM harboring t(2;11)(p11.2;q13), resulting in IGK::CCND1, with cyclin D1 and BCL‐2 overexpression.
Ariel Siegel   +7 more
wiley   +1 more source

Bone Marrow Aspirate Concentrate With Hip Arthroscopy in a Heterogenous Group of Patients May Result in Improved Patient-Reported Outcomes: A Systematic Review. [PDF]

open access: yesHSS J
Lee MS   +12 more
europepmc   +1 more source

What Is Your Diagnosis? Splenic Mass in an African Pygmy Hedgehog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Gabriela Hartmann   +6 more
wiley   +1 more source

Reticulated Platelets and an Optimal Model for Differentiating Thrombocytopenia Etiologies

open access: yeseJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Objectives This study aimed to investigate the clinical value of reticulated platelets (RtcPLT) percentage derived from an automated hematology analyzer in differentiating thrombocytopenia due to peripheral etiology from decreased bone marrow production (BME). In addition, a secondary objective was to establish specific reference intervals for
Tung Thanh Tran   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy